Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.12.010Source: DataRank Database

Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients is a research paper published in Transplantation and Cellular Therapy (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.55)OA: greenTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Anat Stern ORCID,Yeon Joo Lee ORCID,Y. Li ORCID,Parastoo B. Dahi ORCID,Roni Tamari ORCID

Live enrichment

PubMed:39701288 PMC:PMC11936460 OpenAlex:https://openalex.org/W4405494520

National Cancer Institute

Grant: P30 CA008748

National Institutes of Health

Grant: P01 CA23766

NCI NIH HHS

Grant: P01 CA023766

Merck & Co Inc

Meso Scale Diagnostics

FWCI

0.55

Citation Percentile

0.7%

Citation Trend

2025

2026

greenLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11936460/

publisherhttps://api.elsevier.com/content/article/PII:S266663672400811X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S266663672400811X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtct.2024.12.010

Fields of Study

Cytomegalovirus and herpesvirus researchHerpesvirus Infections and TreatmentsParvovirus B19 Infection Studies

MeSH Terms

AcetatesAdultAgedAntiviral AgentsCytomegalovirus InfectionsCytomegalovirusFemaleHumansMaleMiddle AgedQuinazolinesRecurrenceRisk FactorsTransplantation, HomologousHematopoietic Stem Cell TransplantationYoung Adult

Keywords

Hematopoietic cellHaematopoiesisMedicineImmunologyHematopoietic stem cell transplantationVirologyOncologyTransplantationInternal medicineBiologyStem cellGeneticsCytomegalovirusSecondary ProphylaxisHematopoietic Cell TransplantationLetermovirCmv Recurrence